169 related articles for article (PubMed ID: 37803436)
21. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.
Wang Z; Kimura S; Iwasaki H; Takase K; Oshiro Y; Gamachi A; Makihara K; Ogata M; Daa T; Momosaki S; Takamatsu Y; Takeshita M
Diagn Pathol; 2021 Jun; 16(1):48. PubMed ID: 34088321
[TBL] [Abstract][Full Text] [Related]
22. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
23. EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.
Gao J; Behdad A; Ji P; Wolniak KL; Frankfurt O; Chen YH
Mod Pathol; 2017 Aug; 30(8):1100-1115. PubMed ID: 28548121
[TBL] [Abstract][Full Text] [Related]
24. EBV-positive T/NK-associated lymphoproliferative disorders of childhood: A complete autopsy report.
Keow JY; Stecho WM; Haig AR; Sangle NA
Indian J Pathol Microbiol; 2020; 63(1):78-82. PubMed ID: 32031127
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
26. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.
Kim WY; Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
Front Pediatr; 2019; 7():71. PubMed ID: 30931288
[TBL] [Abstract][Full Text] [Related]
28. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
Park JA; Jun KR; Nam SH; Ghim TT
Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
[TBL] [Abstract][Full Text] [Related]
29. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
30. Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus-positive diffuse large B-cell lymphoma, NOS of bone marrow-liver-spleen type: an autopsy case report.
Iizuka H; Mori Y; Iwao N; Koike M; Noguchi M
J Clin Exp Hematop; 2021 Jun; 61(2):102-108. PubMed ID: 33994430
[TBL] [Abstract][Full Text] [Related]
31. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
33. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
[TBL] [Abstract][Full Text] [Related]
34. Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
You E; Park CJ; Lee MY; Cho YU; Jang S; Lee JH; Lee JH; Lee KH
Int J Med Sci; 2023; 20(2):206-210. PubMed ID: 36794163
[TBL] [Abstract][Full Text] [Related]
35. Hematopoietic Bone Marrow Transplant to Treat Systemic EBV-positive T-cell Lymphoma of Childhood.
Manini N; Davidow K; Conard K; Powell J
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e208-e211. PubMed ID: 38117087
[TBL] [Abstract][Full Text] [Related]
36. Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases.
Miao Y; Zhang J; Chen Q; Xing L; Qiu T; Zhu H; Wang L; Fan L; Xu W; Li J
Front Immunol; 2022; 13():970183. PubMed ID: 36032133
[TBL] [Abstract][Full Text] [Related]
37. Chronic active Epstein-Barr virus infection associated with hemophagocytic syndrome and extra-nodal natural killer/T-cell lymphoma in an 18-year-old girl: A case report.
Xing Y; Yang J; Lian G; Chen S; Chen L; Li F
Medicine (Baltimore); 2017 May; 96(19):e6845. PubMed ID: 28489771
[TBL] [Abstract][Full Text] [Related]
38. Epstein Virus Barr-Positive Diffuse Large B-Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis.
Ricard JA; Charles R; Tommee CG; Yohe S; Bell WR; Flanagan ME
J Neuropathol Exp Neurol; 2020 Aug; 79(8):915-920. PubMed ID: 32647871
[TBL] [Abstract][Full Text] [Related]
39. Chronic active Epstein-Barr virus infection progresses to aggressive NK cell leukemia with a poor prognosis.
Hu X; Yang Y; Chen L; Wan Y; Sheng L; Bao Y; Zheng M
Am J Transl Res; 2021; 13(10):12006-12015. PubMed ID: 34786135
[TBL] [Abstract][Full Text] [Related]
40. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study.
Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
